| Year |
Citation |
Score |
| 2021 |
Estes BT, Enomoto M, Moutos FT, Carson MA, Toth JM, Eggert P, Stallrich J, Willard VP, Veis DJ, Little D, Guilak F, Lascelles BDX. Biological resurfacing in a canine model of hip osteoarthritis. Science Advances. 7: eabi5918. PMID 34524840 DOI: 10.1126/sciadv.abi5918 |
0.736 |
|
| 2021 |
Willard VP, Leddy HA, Palmer D, Wu CL, Liedtke W, Guilak F. Transient receptor potential vanilloid 4 as a regulator of induced pluripotent stem cell chondrogenesis. Stem Cells (Dayton, Ohio). PMID 34427363 DOI: 10.1002/stem.3440 |
0.808 |
|
| 2018 |
Adkar SS, Wu CL, Willard VP, Dicks A, Ettyreddy A, Steward N, Bhutani N, Gersbach CA, Guilak F. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing. Stem Cells (Dayton, Ohio). PMID 30378731 DOI: 10.1002/Stem.2931 |
0.804 |
|
| 2018 |
Tang R, Jing L, Willard VP, Wu CL, Guilak F, Chen J, Setton LA. Differentiation of human induced pluripotent stem cells into nucleus pulposus-like cells. Stem Cell Research & Therapy. 9: 61. PMID 29523190 DOI: 10.1186/S13287-018-0797-1 |
0.776 |
|
| 2017 |
Adkar SS, Brunger JM, Willard VP, Wu CL, Gersbach CA, Guilak F. Genome Engineering for Personalized Arthritis Therapeutics. Trends in Molecular Medicine. PMID 28887050 DOI: 10.1016/J.Molmed.2017.08.002 |
0.764 |
|
| 2017 |
Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs. Stem Cell Reports. PMID 28457885 DOI: 10.1016/J.Stemcr.2017.03.022 |
0.771 |
|
| 2016 |
Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. CRISPR/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27813286 DOI: 10.1002/Art.39982 |
0.796 |
|
| 2016 |
Adkar SS, Willard VP, Brunger JM, Shiao KT, Gersbach CA, Guilak F. 318. Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells Molecular Therapy. 24: S128. DOI: 10.1016/S1525-0016(16)33127-6 |
0.786 |
|
| 2015 |
Diekman BO, Thakore PI, O'Connor SK, Willard VP, Brunger JM, Christoforou N, Leong KW, Gersbach CA, Guilak F. Knockdown of the cell cycle inhibitor p21 enhances cartilage formation by induced pluripotent stem cells. Tissue Engineering. Part A. 21: 1261-74. PMID 25517798 DOI: 10.1089/Ten.Tea.2014.0240 |
0.818 |
|
| 2015 |
Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. 504. Targeted Genome Engineering of Induced Pluripotent Stem Cells To Produce Auto-Regulated Inflammation Resistance for Musculoskeletal Regenerative Medicine Molecular Therapy. 23: S201-S202. DOI: 10.1016/S1525-0016(16)34113-2 |
0.799 |
|
| 2014 |
Willard VP, Diekman BO, Sanchez-Adams J, Christoforou N, Leong KW, Guilak F. Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening. Arthritis & Rheumatology (Hoboken, N.J.). 66: 3062-72. PMID 25047145 DOI: 10.1002/Art.38780 |
0.794 |
|
| 2013 |
Willard V, Diekman B, Sanchez-Adams J, O'Connor S, Christoforou N, Leong K, Guilak F. Osteoarthritis in a dish: the effects of pro-inflammatory cytokines on cartilage derived from induced pluripotent stem cells Osteoarthritis and Cartilage. 21: S281-S282. DOI: 10.1016/J.Joca.2013.02.590 |
0.772 |
|
| 2012 |
Diekman BO, Christoforou N, Willard VP, Sun H, Sanchez-Adams J, Leong KW, Guilak F. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 19172-7. PMID 23115336 DOI: 10.1073/Pnas.1210422109 |
0.817 |
|
| 2012 |
Willard VP, Kalpakci KN, Reimer AJ, Athanasiou KA. The regional contribution of glycosaminoglycans to temporomandibular joint disc compressive properties. Journal of Biomechanical Engineering. 134: 011011. PMID 22482666 DOI: 10.1115/1.4005763 |
0.713 |
|
| 2012 |
Willard VP, Arzi B, Athanasiou KA. The attachments of the temporomandibular joint disc: a biochemical and histological investigation. Archives of Oral Biology. 57: 599-606. PMID 22129470 DOI: 10.1016/J.Archoralbio.2011.10.004 |
0.698 |
|
| 2012 |
Huey DJ, Sanchez-Adams J, Willard VP, Athanasiou KA. Immunogenicity of bovine and leporine articular chondrocytes and meniscus cells. Tissue Engineering. Part A. 18: 568-75. PMID 21942992 DOI: 10.1089/Ten.Tea.2011.0226 |
0.747 |
|
| 2011 |
Sanchez-Adams J, Willard VP, Athanasiou KA. Regional variation in the mechanical role of knee meniscus glycosaminoglycans. Journal of Applied Physiology (Bethesda, Md. : 1985). 111: 1590-6. PMID 21903884 DOI: 10.1152/Japplphysiol.00848.2011 |
0.764 |
|
| 2011 |
Kalpakci KN, Willard VP, Wong ME, Athanasiou KA. An interspecies comparison of the temporomandibular joint disc Journal of Dental Research. 90: 193-198. PMID 21118792 DOI: 10.1177/0022034510381501 |
0.688 |
|
| 2011 |
Willard VP, Zhang L, Athanasiou KA. Tissue engineering of the temporomandibular joint Comprehensive Biomaterials. 5: 221-235. DOI: 10.1016/B978-0-08-055294-1.00250-6 |
0.608 |
|
| 2011 |
Arzi B, Willard VP, Huey DJ, Verstraete FJM, Vapniarsky-Arzi N, Athanasiou KA. The temporomandibular joint disc of Asian elephant (Elephas maximus) and African elephant (Loxodonta africana) European Journal of Wildlife Research. 58: 451-459. DOI: 10.1007/S10344-011-0595-X |
0.757 |
|
| 2009 |
Ofek G, Willard VP, Koay EJ, Hu JC, Lin P, Athanasiou KA. Mechanical characterization of differentiated human embryonic stem cells. Journal of Biomechanical Engineering. 131: 061011. PMID 19449965 DOI: 10.1115/1.3127262 |
0.79 |
|
| 2009 |
Hoben GM, Willard VP, Athanasiou KA. Fibrochondrogenesis of hESCs: growth factor combinations and cocultures. Stem Cells and Development. 18: 283-92. PMID 18454697 DOI: 10.1089/Scd.2008.0024 |
0.794 |
|
| Show low-probability matches. |